Loading clinical trials...

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 1/2NCT05902988

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.

Lead sponsor: Volastra Therapeutics, Inc.•14 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Volastra Therapeutics, Inc.

CONTACT

(646) 344-1248 clinicaltrials@volastratx.com

Sponsors

Lead Sponsor

Volastra Therapeutics, Inc.

Related studies

RECRUITINGPhase 1/2

Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more

RECRUITINGPhase 1

A Phase I Study of BAY3498264 Given Together With Sotorasib in Participants Who Have Advanced Solid Cancers With Specific Genetic Changes Called KRASG12C Mutation

NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation

RECRUITINGPhase 1/2

Study of SGN1 in Patients With Advanced Solid Tumor

NCT05038150 · Advanced Solid Tumor

RECRUITINGPhase 1

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937 · Small Cell Lung Cancer, Melanoma, and more

RECRUITINGPhase 1

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

NCT07181681 · Solid Tumors, Advanced Solid Tumor

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 4, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE1/PHASE2

Enrollment200

Start dateOct 2023

Last updatedNov 4, 2025

Condition

Advanced Solid Tumor High Grade Serous Adenocarcinoma of Ovary Squamous Non-small-cell Lung Cancer Triple Negative Breast Cancer Head and Neck Squamous Cell Carcinoma+5 more

Locations shown

University of Southern California

Los Angeles, California

Hoag Memorial Hospital

Newport Beach, California

University of Colorado Cancer Center

Aurora, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 4, 2025Data synced to Clareo: May 16, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions